Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRD303 Solution for Postoperative Analgesia After Unilateral Hip Arthroplasty (Phase II)
CTR20244966Phase 2Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRD303 in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Jan 2025; status: completed.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20244966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244966.